Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.

Tytuł:
Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.
Autorzy:
Ali MM; Hawassa University College of Medicine and Health Sciences, School of Medical laboratory Science, Hawassa, Ethiopia. .
Woldeamanuel Y; Department of Microbiology, Immunology and Parasitology, Addis Ababa University College of Health Science, Addis Ababa, Ethiopia.
Asrat D; Department of Microbiology, Immunology and Parasitology, Addis Ababa University College of Health Science, Addis Ababa, Ethiopia.
Fenta DA; Hawassa University College of Medicine and Health Sciences, School of Medical laboratory Science, Hawassa, Ethiopia.
Beall B; Respiratory Diseases Branch, Centers of Disease Control and Prevention (CDC), Atlanta, USA.
Schrag S; Respiratory Diseases Branch, Centers of Disease Control and Prevention (CDC), Atlanta, USA.
McGee L; Respiratory Diseases Branch, Centers of Disease Control and Prevention (CDC), Atlanta, USA.
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Nov 16; Vol. 20 (1), pp. 848. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, [2001-
MeSH Terms:
Genotype*
Serogroup*
Pregnancy Complications, Infectious/*diagnosis
Streptococcal Infections/*diagnosis
Streptococcus agalactiae/*genetics
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Cross-Sectional Studies ; Drug Resistance, Bacterial/drug effects ; Ethiopia/epidemiology ; Female ; Humans ; Infant, Newborn ; Microbial Sensitivity Tests ; Multilocus Sequence Typing ; Pregnancy ; Pregnancy Complications, Infectious/epidemiology ; Pregnancy Complications, Infectious/microbiology ; Prospective Studies ; Sepsis/diagnosis ; Streptococcal Infections/drug therapy ; Streptococcal Infections/epidemiology ; Streptococcal Infections/microbiology ; Streptococcus agalactiae/isolation & purification ; Whole Genome Sequencing
References:
Can J Infect Dis Med Microbiol. 2016;2016:6403928. (PMID: 27559344)
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S125-S132. (PMID: 29117322)
Lancet Infect Dis. 2016 May;16(5):546-555. (PMID: 26869376)
J Clin Microbiol. 2003 Jun;41(6):2530-6. (PMID: 12791877)
Vaccine. 2016 Jun 3;34(26):2876-2879. (PMID: 26988258)
Microbiol Spectr. 2019 Mar;7(2):. (PMID: 30873933)
J Microbiol Methods. 2010 Feb;80(2):212-4. (PMID: 19958797)
Obstet Gynecol. 2014 Apr;123(4):828-37. (PMID: 24785612)
BMC Res Notes. 2016 Jul 19;9:351. (PMID: 27435469)
Antimicrob Agents Chemother. 2015 Apr;59(4):2466-9. (PMID: 25666148)
J Antimicrob Chemother. 2015;70(6):1601-3. (PMID: 25667406)
J Clin Microbiol. 2007 Sep;45(9):2929-36. (PMID: 17634306)
Microbes Infect. 2006 Jun;8(7):1714-22. (PMID: 16822689)
J Infect Dis. 2009 Jan 1;199(1):108-15. (PMID: 19086816)
Pediatr Infect Dis J. 2016 Sep;35(9):933-42. (PMID: 27213263)
J Exp Med. 2010 Oct 25;207(11):2313-22. (PMID: 20956545)
Ann Clin Microbiol Antimicrob. 2019 Jan 19;18(1):3. (PMID: 30660188)
Nat Commun. 2014 Aug 04;5:4544. (PMID: 25088811)
J Bacteriol. 2004 Mar;186(5):1518-30. (PMID: 14973027)
J Infect Dis. 2012 Dec 1;206(11):1745-52. (PMID: 23002446)
Cell Host Microbe. 2007 Dec 13;2(6):427-34. (PMID: 18078694)
Emerg Infect Dis. 2015 Apr;21(4):585-91. (PMID: 25811284)
Pediatr Infect Dis J. 2003 Feb;22(2):e1-11. (PMID: 12586987)
Indian J Med Res. 2004 May;119 Suppl:205-7. (PMID: 15232196)
Mem Inst Oswaldo Cruz. 2011 Mar;106(2):119-22. (PMID: 21537668)
BMC Res Notes. 2015 Aug 20;8:364. (PMID: 26289147)
Antimicrob Agents Chemother. 2008 May;52(5):1888-90. (PMID: 18299411)
Med Princ Pract. 2014;23(4):323-30. (PMID: 24820221)
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S100-S111. (PMID: 29117327)
BMC Pregnancy Childbirth. 2018 May 4;18(1):135. (PMID: 29728084)
BMC Infect Dis. 2020 Jan 13;20(1):35. (PMID: 31931732)
Ann Lab Med. 2019 Jul;39(4):414-416. (PMID: 30809991)
Ann Clin Microbiol Antimicrob. 2019 Mar 28;18(1):14. (PMID: 30922308)
J Antimicrob Chemother. 2017 Jul 1;72(7):1886-1892. (PMID: 28333320)
Clin Microbiol Infect. 2017 Aug;23(8):574.e7-574.e14. (PMID: 28257899)
Clin Infect Dis. 2020 Feb 15;:. (PMID: 32060499)
PLoS One. 2017 Aug 15;12(8):e0183083. (PMID: 28813477)
Contributed Indexing:
Keywords: Antibiotic resistance; GBS; S. agalactiae; Sequence type; Serotype
Substance Nomenclature:
0 (Anti-Bacterial Agents)
Entry Date(s):
Date Created: 20201117 Date Completed: 20201207 Latest Revision: 20201214
Update Code:
20240105
PubMed Central ID:
PMC7668015
DOI:
10.1186/s12879-020-05581-8
PMID:
33198686
Czasopismo naukowe
Background: Streptococcus agalactiae (Group B Streptococcus, GBS) serotypes, sequence types, and antimicrobial resistance profile vary across different geographic locations affecting disease patterns in newborns. These differences are important considerations for vaccine development efforts and data from large countries in Africa is limited. The aim of this study was to determine serotypes and genotypes of GBS isolates from pregnant women and their newborns in Ethiopia.
Methods: A hospital based cross-sectional study was conducted at three hospitals in Ethiopia from June 2014 to September 2015. Out of 225 GBS isolates, 121 GBS were recovered, confirmed and characterized at CDC's Streptococcus Laboratory using conventional microbiology methods and whole genome sequencing.
Results: Of the 121 isolates, 87 were from rectovaginal samples of pregnant women, 32 from different body parts of their newborns and 2 from blood of newborns with suspected sepsis. There were 25 mother-infant pairs and 24 pairs had concordant strains. The most prevalent serotypes among mothers and/or their babies were II, Ia and V (41.5, 20.6, 19.5 and 40.6%, 25 and 15.6%, respectively). Multilocus sequence typing (MLST) on 83 isolates showed ST10 (24; 28.9%) and ST2 (12; 14.5%) as most predominant sequence types. All GBS strains were susceptible to penicillin, cefotaxime and vancomycin, which correlated to the presence of wildtype PBP2x types and the lack of known vancomycin-resistance genes. Tetracycline resistance was high (73; 88%, associated primarily with tetM, but also tetO and tetL). Five isolates (6%) were resistant to erythromycin and clindamycin and 3 isolates were fluoroquinolone-resistant, containing associated mutations in gyrA and parC genes. All isolates were positive for one of four homologous Alpha/Rib family determinants and 1-2 of the three main pilus types.
Conclusions: Predominant serotypes were II, Ia, and V. A limited number of clonal types were identified with two STs accounting for about half of the isolates. All strains collected in this study were susceptible to beta-lactam antibiotics and vancomycin. Typical of most GBS, these isolates were positive for single alpha-like family protein, serine-rich repeat gene, as well as 1-2 pilus determinants.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies